Patent details

300825 Product Name: Lesinurad

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300825
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2135608
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300825
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1080
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/02/2016
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
28/07/2016
First Marketing Authorization date:
22/02/2016
Grant date:
24/01/2017
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
02/08/2016
SPC/SPC Extension Expiration Date:
24/08/2030
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
02/08/2016
 
 

 

Name:
Ardea Biosciences, Inc.
Address:
9390 Towne Centre Drive, SAN DIEGO, CA 92121, United States of America (US)

Agent

Name:
ir. J.C. Volmer c.s.
From:
02/08/2016
Address:
Exter Polak & Charlouis B.V. Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
14/21
Publication date:
07/04/2021
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
04/17
Publication date:
25/01/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
31/16
Publication date:
03/08/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/08/2025
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
24/01/2017 Outgoing Correspondence Decision grant 1 PDF /3/9/3/5/7/0800075393/docs/300825_11_outgoingcorrespondence20170124101812968.pdf
24/01/2017 SPC Documents Certificate SPC 1 PDF /3/9/3/5/7/0800075393/docs/300825_12_supplprotectioncertificate20170124101744438.pdf
17/01/2017 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /3/9/3/5/7/0800075393/docs/300825_1_incomingcorrespondencepaper20210407012624171.pdf
19/10/2016 Outgoing Correspondence Outgoing Letter 2 PDF /3/9/3/5/7/0800075393/docs/300825_9_outgoingcorrespondence20161019011010727.pdf
02/08/2016 Outgoing Correspondence Confirmation receipt request 1 PDF /3/9/3/5/7/0800075393/docs/300825_8_outgoingcorrespondence20210107034959799.pdf
28/07/2016 SPC Documents Marketing Authorization SPC 3 PDF /3/9/3/5/7/0800075393/docs/300825_0_supplprotectioncertificate20160802073724493.pdf
28/07/2016 SPC Documents Accompanying letter SPC 2 PDF /3/9/3/5/7/0800075393/docs/300825_2_supplprotectioncertificate20210107034841123.pdf
28/07/2016 SPC Documents Annex SPC 1 PDF /3/9/3/5/7/0800075393/docs/300825_3_supplprotectioncertificate20160802073724420.pdf
28/07/2016 Application Form First filed application form 2 PDF /3/9/3/5/7/0800075393/docs/300825_4_applicationform20160802073724095.pdf
28/07/2016 SPC Documents Annex SPC 3 PDF /3/9/3/5/7/0800075393/docs/300825_5_supplprotectioncertificate20210107034651361.pdf
28/07/2016 SPC Documents Annex SPC 3 PDF /3/9/3/5/7/0800075393/docs/300825_6_supplprotectioncertificate20210107032237894.pdf
28/07/2016 SPC Documents Annex SPC 13 PDF /3/9/3/5/7/0800075393/docs/300825_7_supplprotectioncertificate20210107034651421.pdf
28/07/2016 SPC Documents Summary of the characteristics of the product 16 PDF /3/9/3/5/7/0800075393/docs/300825_10_supplprotectioncertificate20210107034651277.pdf